Patents by Inventor Nagabasayya R Chikkamath

Nagabasayya R Chikkamath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LONG-ACTING INJECTION DOSAGE FORM OF BETA 3 ADRENORECEPTOR AGONISTS
    Publication number: 20230012402
    Abstract: Provided herein are the long-acting injection compositions of ?3 adrenoreceptor agonists like mirabegron or their pharmaceutically acceptable salts or esters thereof. The present invention also relates to methods for preparing long-acting injection compositions and methods of using the prepared dosage forms for the removal of undesirable body fat for the treatment of obesity, metabolic diseases, and other diseases as described herein. The long-acting injection compositions as per the present invention have desirable pharmaceutical technical and clinical attributes.
    Type: Application
    Filed: September 8, 2022
    Publication date: January 12, 2023
    Applicant: Jubilant Pharma Holdings Inc.
    Inventors: Indranil Nandi, Nagabasayya R. Chikkamath, Dinesh Kumar, Tusharmouli Mukherjee
  • PARENTERAL DOSAGE FORM OF BETA 3 ADRENORECEPTOR AGONISTS
    Publication number: 20230000837
    Abstract: Disclosed are the injection compositions of ?3 adrenoreceptor agonists such as mirabegron or their pharmaceutically acceptable salts or solvates or esters thereof. The present invention also relates to methods for preparing injection compositions and methods of using these dosage forms for the treatment of obesity, other related metabolic diseases, and reduction/removal of fat. The injection compositions as per the present invention have advantages of simple preparation, simple and convenient application, easy absorption, and better effect of treating. The compositions can also be used in cases where oral administration of the drug is not possible due to underlying conditions or concerns around inadequate oral absorption. The injection compositions as per the present invention have desirable pharmaceutical technical attributes.
    Type: Application
    Filed: April 20, 2022
    Publication date: January 5, 2023
    Applicant: Jubilant Pharma Holdings Inc.
    Inventors: Indranil Nandi, Tusharmouli Mukherjee, Nagabasayya R. Chikkamath
  • Parenteral dosage form of ?3 adrenoreceptor agonists
    Patent number: 11311518
    Abstract: Disclosed are the injection compositions of ?3 adrenoreceptor agonists such as mirabegron or their pharmaceutically acceptable salts or solvates or esters thereof. The present invention also relates to methods for preparing injection compositions and methods of using these dosage forms for the treatment of obesity, other related metabolic diseases, and reduction/removal of fat. The injection compositions as per the present invention have advantages of simple preparation, simple and convenient application, easy absorption, and better effect of treating. The compositions can also be used in cases where oral administration of the drug is not possible due to underlying conditions or concerns around inadequate oral absorption. The injection compositions as per the present invention have desirable pharmaceutical technical attributes.
    Type: Grant
    Filed: August 6, 2021
    Date of Patent: April 26, 2022
    Assignee: Jubilant Pharma Holdings Inc.
    Inventors: Indranil Nandi, Tusharmouli Mukherjee, Nagabasayya R Chikkamath